PA8431101A1 - Antagonistas de receptor de benzoxazinona dopamina d4. - Google Patents

Antagonistas de receptor de benzoxazinona dopamina d4.

Info

Publication number
PA8431101A1
PA8431101A1 PA19978431101A PA8431101A PA8431101A1 PA 8431101 A1 PA8431101 A1 PA 8431101A1 PA 19978431101 A PA19978431101 A PA 19978431101A PA 8431101 A PA8431101 A PA 8431101A PA 8431101 A1 PA8431101 A1 PA 8431101A1
Authority
PA
Panama
Prior art keywords
dopamine
benzoxazinone
receptor antagonists
receiver
antagonists
Prior art date
Application number
PA19978431101A
Other languages
English (en)
Inventor
David Juergen Wustrow
Thomas Belliotti
Lawrence David Wise
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PA8431101A1 publication Critical patent/PA8431101A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

ESTA INVENCION SE RELACIONA CON COMPUESTOS QUE SON ANTAGONISTAS DE RECEPTORES DE DOPAMINA D4, CON METODOS PARA TRATAR LA PSICOSIS Y LA ESQUIZOFRENIA USANDO UN COMPUESTO QUE ES UN ANTAGONISTA DE RECEPTORES DE DOPAMINA D4 Y CON COMPOSICIONES FARMACOLOGICAMENTE ACEPTABLES QUE CONTIENEN UN ANTAGONISTA DE RECEPTOR DE DOPAMINA D4.
PA19978431101A 1996-05-29 1997-05-28 Antagonistas de receptor de benzoxazinona dopamina d4. PA8431101A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1838396P 1996-05-29 1996-05-29
US4020897P 1997-03-06 1997-03-06

Publications (1)

Publication Number Publication Date
PA8431101A1 true PA8431101A1 (es) 2001-12-14

Family

ID=26691052

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19978431101A PA8431101A1 (es) 1996-05-29 1997-05-28 Antagonistas de receptor de benzoxazinona dopamina d4.

Country Status (37)

Country Link
EP (1) EP0906294B1 (es)
JP (1) JP2000511534A (es)
KR (1) KR20000016151A (es)
CN (1) CN1074764C (es)
AR (1) AR008372A1 (es)
AT (1) ATE231846T1 (es)
AU (1) AU731104B2 (es)
BG (1) BG64049B1 (es)
BR (1) BR9709630A (es)
CA (1) CA2253406A1 (es)
CO (1) CO4940505A1 (es)
CZ (1) CZ384698A3 (es)
DE (1) DE69718786T2 (es)
DK (1) DK0906294T3 (es)
EA (1) EA001486B1 (es)
EE (1) EE03686B1 (es)
ES (1) ES2191180T3 (es)
GE (1) GEP20012389B (es)
HK (1) HK1019737A1 (es)
HN (1) HN1997000075A (es)
HR (1) HRP970301B1 (es)
HU (1) HUP9903758A3 (es)
ID (1) ID17266A (es)
IL (1) IL126895A (es)
NO (1) NO312296B1 (es)
NZ (1) NZ332737A (es)
PA (1) PA8431101A1 (es)
PE (1) PE69398A1 (es)
PL (1) PL330195A1 (es)
PT (1) PT906294E (es)
RO (1) RO120845B1 (es)
SI (1) SI0906294T1 (es)
SK (1) SK282703B6 (es)
SV (1) SV1997000047A (es)
TW (1) TW542833B (es)
UY (1) UY24569A1 (es)
WO (1) WO1997045419A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177422B1 (en) 1996-05-29 2001-01-23 Warner-Lambert Company Benzoxazinone dopamine D4 receptor antagonists
GB9801392D0 (en) * 1998-01-22 1998-03-18 Smithkline Beecham Plc Novel compounds
US6291463B1 (en) 1998-06-30 2001-09-18 Neurogen Corporation 1-(Benzothiazol-2-yl)-4-(1-phenylmethyl) piperazines: dopamine receptor subtype specific ligands
WO2000000482A1 (en) * 1998-06-30 2000-01-06 Neurogen Corporation 1-(benzothiazol-2-yl)-4-(1-phenylmethyl)piperazines: dopamine receptor subtype specific ligands
EP1091949A2 (en) * 1998-06-30 2001-04-18 Neurogen Corporation 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands
US6177566B1 (en) 1998-06-30 2001-01-23 Neurogen Corporation 6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(4-arylalkylpiperazin-1-yl) chromane derivatives: dopamine receptor subtype specific ligands
DE19844291A1 (de) * 1998-09-18 2000-03-23 Schering Ag Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln
GB9912411D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
DE60127434T2 (de) 2000-10-26 2007-11-29 Smithkline Beecham P.L.C., Brentford Benzoxazinonderivative, deren herstellung und verwendung
GB0203804D0 (en) 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0209244D0 (en) * 2002-04-23 2002-06-05 Glaxo Group Ltd Compounds
GB0227240D0 (en) * 2002-11-21 2002-12-31 Glaxo Group Ltd Compounds
ES2232292B1 (es) * 2003-07-30 2006-11-01 Laboratorios Del Dr. Esteve, S.A. Compuestos sulfonamidicos derivados de benzoxazinona, su preparacion y uso como medicamentos.
CN100455573C (zh) * 2005-11-11 2009-01-28 华东理工大学 一种制备1,4-苯并噁唑嗪-3-酮化合物的微波合成方法
KR200482995Y1 (ko) 2015-08-19 2017-03-23 이현진 물 공급부를 구비하는 얼음 트레이
CA3215823A1 (en) * 2021-04-23 2022-10-27 Peng Gao Heterocyclic derivative inhibitor and preparation method therefor and application thereof
WO2023207283A1 (en) * 2022-04-28 2023-11-02 Ningbo Newbay Technology Development Co., Ltd Compounds as parp1 inhibitiors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613598A (en) * 1984-03-13 1986-09-23 Mitsubishi Chemical Industries Limited Piperazine derivatives and their acid addition salts
EP0233728A1 (en) * 1986-02-11 1987-08-26 Takeda Chemical Industries, Ltd. 1,4-Benzoxazine derivatives their production and use
US5523299A (en) * 1992-08-06 1996-06-04 Smithkline Beecham Plc 5-(2-oxyphenyl)-pyrrole derivatives as dopamine D3 receptor antagonists

Also Published As

Publication number Publication date
JP2000511534A (ja) 2000-09-05
SI0906294T1 (en) 2003-04-30
WO1997045419A1 (en) 1997-12-04
ES2191180T3 (es) 2003-09-01
EE03686B1 (et) 2002-04-15
AU3072797A (en) 1998-01-05
TW542833B (en) 2003-07-21
SV1997000047A (es) 1998-08-13
NO312296B1 (no) 2002-04-22
DE69718786D1 (de) 2003-03-06
GEP20012389B (en) 2001-03-25
CA2253406A1 (en) 1997-12-04
BG64049B1 (bg) 2003-11-28
ATE231846T1 (de) 2003-02-15
NO985531L (no) 1998-11-27
HUP9903758A2 (hu) 2000-06-28
PT906294E (pt) 2003-06-30
EE9800417A (et) 1999-06-15
BR9709630A (pt) 1999-08-10
PE69398A1 (es) 1998-12-02
HRP970301B1 (en) 2002-08-31
KR20000016151A (ko) 2000-03-25
CZ384698A3 (cs) 1999-03-17
EA001486B1 (ru) 2001-04-23
HN1997000075A (es) 1997-07-30
PL330195A1 (en) 1999-04-26
DK0906294T3 (da) 2003-05-05
ID17266A (id) 1997-12-18
BG102959A (en) 1999-08-31
AR008372A1 (es) 2000-01-19
SK282703B6 (sk) 2002-11-06
EA199800987A1 (ru) 1999-06-24
EP0906294B1 (en) 2003-01-29
CO4940505A1 (es) 2000-07-24
EP0906294A1 (en) 1999-04-07
SK162798A3 (en) 1999-06-11
RO120845B1 (ro) 2006-08-30
UY24569A1 (es) 2001-08-27
NO985531D0 (no) 1998-11-27
NZ332737A (en) 2000-06-23
AU731104B2 (en) 2001-03-22
HK1019737A1 (en) 2000-02-25
CN1219930A (zh) 1999-06-16
IL126895A (en) 2001-06-14
DE69718786T2 (de) 2003-10-23
IL126895A0 (en) 1999-09-22
HUP9903758A3 (en) 2000-07-28
CN1074764C (zh) 2001-11-14
HRP970301A2 (en) 1998-04-30

Similar Documents

Publication Publication Date Title
PA8431101A1 (es) Antagonistas de receptor de benzoxazinona dopamina d4.
ES2196534T3 (es) Antagonistas del receptor de vitronectina.
MXPA00010060A (es) Receptores de serotonina humana constitutivamente activados, no endogenos y moduladores de molecula pequenos de los mismos.
HN1999000149A (es) Derivados de 4,4-biarilpiperidina
ES2172535T3 (es) Antagonistas de los receptores de la endotelina.
ECSP014130A (es) Compuestos heterociclicos como ligandos de los receptores gaba.
HN1998000157A (es) Agonistas de prostaglandinas
AUPO755097A0 (en) Receptor agonist and antagonist
PA8442601A1 (es) Peptidos y compuestos que se enlazan a un receptor
PA8456601A1 (es) 4-aminopirrol (3,2-d) pirimidinas como antagonistas del receptor del neuropeptido y
NO983431L (no) Anti-klöemidler
CR6478A (es) Moduladores del receptor glucocorticoide
BR9206237A (pt) Uso de derivados de tetrahidrocarbazole como receptores agonistas 5-HT1.
ES2123482T3 (es) Receptor de estrogeno.
SV2004001250A (es) Agonistas muscarinicos ref, x - 15335
ES2152328T3 (es) Antagonistas del receptor del fibrinogeno.
ES2156889T3 (es) Compuestos biciclicos antagonistas de receptores de aminoacidos excitativos.
ES2188936T3 (es) Antagonistas del receptor alfa-q-adrenergico.
EA199800185A1 (ru) Антагонисты рецепторов эндотелина
ECSP972135A (es) Antagonistas de receptor de benzoxazinona dopamina d4
EA200100182A1 (ru) Лечение состояний тревожности
ES2155187T3 (es) Antagonistas biciclicos de taquicinas, preparacion de estos antagonistas y su utilizacion en compuestos farmaceuticos.
EA200000197A1 (ru) 2-ациламинопропанамины в качестве антагонистов рецепторов тахикининов
HN1999000082A (es) 3-ceto derivados triciclicos de 6-0- metileritromicina.
BR9801049A (pt) Processo para a preparação de um composto de -clorocetona e, - didiclorocetona e uso de ácido tricloro cianúrico.